ARAnne Christin Rahn

Anne Christin Rahn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne Christin Rahn has a total of 268 co-authors. Here are the top co-authors by number of shared publications:

  • Christoph Heesen

    Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    9 shared publications
  • Sascha Köpke

    Faculty of Medicine and University Hospital Cologne, Institute of Nursing Science University of Cologne Cologne Germany

    7 shared publications
  • Christoph Heesen

    Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    6 shared publications
  • Sascha Köpke

    Institute of Nursing Science, University of Cologne, Cologne, Germany

    6 shared publications
  • Jutta Scheiderbauer

    Foundation for Self-Determination and Self-Representation of MS-Patients, Trier, Germany

    4 shared publications
  • Alessandra Solari

    Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

    3 shared publications

Latest Publications

  • Open Access

    Perspectives of participating neurologists and study nurses - Mixed-methods process evaluation of a web-based program for relapse management in multiple sclerosis (POWER@M2)

    by Lea Bremer, Julia Hickstein, Lisa Wenzel, Jutta Scheiderbauer, Markus Van de Loo, Anne Christin Rahn, Christoph Heesen, Sascha Köpke

  • Open Access

    Educational interventions for improving health-related literature searching skills of health professionals and students

    by Julian Hirt, Magdalena Vogt, Janine Vetsch, Martin N Dichter, Jasmin Eppel-Meichlinger, Hannah Ewald, Ralph Möhler, Martin Mueller, Anne C Rahn, Gabriele Meyer, et al.

    Objectives This is a protocol for a Cochrane Review (methodology). The objectives are as follows: To evaluate the effects of educational interventions for improving health‐related literature searching skills of health professionals and students.


  • Open Access

    Informed Decision-Making About COVID-19 Vaccination – Development and Feasibility of a Decision Support Intervention: A Mixed-Methods Study

    by Jana Kaden, Julia Peper, Anne C. Rahn, Birte Berger-Höger

    Many people, particularly from vulnerable groups, experienced decisional conflict regarding COVID-19 vaccination. To support informed decision-making, we developed and pilot-tested a decision support intervention consisting of a patient decision aid and non-directive decision coaching led by a trained health professional. We developed a training program to prepare healthcare professionals to implement the intervention. To assess the decisional needs of unvaccinated individuals, a literature review and a focus group with community health workers were conducted. The results informed the development of the intervention and the associated training for health professionals, which were then tested regarding their comprehensibility, feasibility, and acceptance. Fourteen health professionals completed a 540-minute training and participated in guided focus groups. The decision support intervention was subsequently tested with laypeople through guided interviews. Data were analyzed via qualitative content analysis. The training was feasible and well accepted, and the competencies to provide decision coaching were acquired. The decision coaching offer was tested in two real and seven simulated sessions. The patient decision aid, comprising an evidence-based COVID-19 information sheet and a decision guidance, was comprehensible and highly accepted by all participants. While the intervention proved feasible, access to vulnerable groups and their willingness to participate remained low.


  • Open Access

    Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) – A cluster- randomised controlled trial and mixed methods process evaluation

    by A.C. Rahn, J. Peper, S. Köpke, G. Antony, K. Liethmann, E. Vettorazzi, C. Heesen, Martin Berghoff, Ricarda Diem, Jürgen H. Faiss, et al.


  • Open Access

    Determinants of practice for providing decision coaching to facilitate informed values-based decision-making: protocol for a mixed-methods systematic review

    by Birte Berger-Höger, Krystina B Lewis, Katherine Cherry, Jeanette Finderup, Janet Gunderson, Jana Kaden, Simone Kienlin, Anne C Rahn, Lindsey Sikora, Dawn Stacey, et al.

    Introduction Decision coaching is a non-directive approach to support patients to prepare for making health decisions. It is used to facilitate patients’ involvement in informed values-based decision-making and use of evidence-based health information. A recent systematic review revealed low certainty evidence for its effectiveness with and without evidence-based information. However, there may be opportunities to improve the study and use of decision coaching in clinical practice by systematically investigating its determinants of practice. We aim to conduct a systematic review to identify and synthesise the determinants of practice for providing decision coaching to facilitate patient involvement in decision-making from multiple perspectives that influence its use. Methods and analysis We will conduct a mixed-methods systematic review guided by the Cochrane’ Handbook of Systematic Reviews. We will include studies reporting determinants of practice influencing decision coaching with or without evidence-based patient information with adults making a health decision for themselves or a family member. Systematic literature searches will be conducted in Medline, EMBASE, Cochrane CENTRAL and PsycINFO via Ovid and CINAHL via EBSCO including quantitative, qualitative and mixed-methods study designs. Additionally, experts in the field will be contacted. Two reviewers will independently screen and extract data. We will synthesise determinants using deductive and inductive qualitative content analysis and a coding frame developed specifically for this review based on a taxonomy of barriers and enablers of shared decision-making mapped onto the major domains of the Consolidated Framework for Implementation Research. We will assess the quality of included studies using the Mixed Methods Appraisal Tool. Ethics and dissemination Ethical approval is not required as this systematic review involves only previously published literature. The results will be published in a peer-reviewed journal, presented at scientific conferences and disseminated to relevant consumer groups. PROSPERO registration number CRD42022338299.


  • Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis

    by Charlotte Schubert, Lea Steinberg, Julia Peper, Caren Ramien, Kerstin Hellwig, Sascha Köpke, Alessandra Solari, Andrea Giordano, Stefan M Gold, Tim Friede, et al.

    The influence of pregnancy on the course of multiple sclerosis (MS) has long been controversial. While historical evidence suggests a substantial decline in relapse rates during pregnancy followed by a rebound in the postpartum period, more recent work yielded equivocal results. We performed a systematic review and meta-analysis on data from cohort studies to determine whether women with MS experience increased relapse rates after delivery. A systematic literature search was conducted in the databases MEDLINE and Epistemonikos on the topic ‘motherhood choice in MS’ in March 2022. We included cohort studies assessing the association between pregnancy and MS relapse activity defined by the annualised relapse rate after 3, 6, 9 and 12 months post partum. Furthermore, information about disease-modifying therapies (DMT) and breast feeding was considered, if available. 5369 publications were identified. Of these, 93 full-text articles on MS relapse activity during the postpartum period were screened. 11 studies including 2739 pregnancies were eligible. Women with MS showed a significantly increased relapse rate in the first 6 months post partum, compared with preconception with the incidence rate ratio (IRR) almost doubled in the first 3 months post partum (1.87, 95% CI 1.40 to 2.50). However, at 10–12 months post partum, the IRR decreased significantly (0.81, 95% CI 0.67 to 0.98). Subanalysis on influencing parameters suggested that preconceptional DMTs (IRR for highly-effective DMTs 2.76, 95% CI 1.34 to 5.69) and exclusive breast feeding (risk ratio 0.39, 95% CI 0.18 to 0.86) significantly influenced postpartum relapse risk. Increased postpartum annualised relapse rate and possible modifiers should be considered in counselling women with MS who are considering pregnancy.


  • Open Access

    Specialised nursing tasks in cancer care and their effects

    by Teresa Witzke, Adele Stojanov, Johanna Ristau, Birte Berger-Höger, Christina Louise Lindhardt, Katrin Balzer, Anne Christin Rahn

    Background: Several reviews are available on the effects of specific nursing tasks in oncology care. However, a synthesis across cancer entities and stages is lacking. Aim: To synthesise ... Spezialisierte pflegerische Aufgaben in der Onkologie und deren Effekte: Ein systematisches Umbrella Review Zusammenfassung. Hintergrund: Es liegen mehrere Reviews zu den Effekten spezieller pflege...


  • Open Access

    Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol

    by Thomas Lehnert, Christian Röver, Sascha Köpke, Jordi Rio, Declan Chard, Andrea V. Fittipaldo, Tim Friede, Christoph Heesen, Anne C. Rahn

    Background: Multiple sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system with an increasing worldwide prevalence. Since 1993, more than 15 disease-modifying immunotherapies (DMTs) have been licenced and have shown moderate efficacy in clinical trials. Based on the heterogeneity of the disease and the partial effectiveness of therapies, a personalised medicine approach would be valuable taking individual prognosis and suitability of a chosen therapy into account to gain the best possible treatment effect. The primary objective of this review is to assess the differential treatment effects of all approved DMTs in subgroups of adults with clinically isolated syndrome or relapsing forms of MS. We will analyse possible treatment effect modifiers (TEM) defined by baseline demographic characteristics (gender, age), and diagnostic (i.e. MRI measures) and clinical (i.e. relapses, disability level) measures of MS disease activity. Methods: We will include all published and accessible unpublished primary and secondary analyses of randomised controlled trials (RCTs) with a follow-up of at least 12 months investigating the efficacy of at least one approved DMT, with placebo or other approved DMTs as control intervention(s) in subgroups of trial participants. As the primary outcome, we will address disability as defined by the Expanded Disability Status Scale or multiple sclerosis functional composite scores followed by relapse frequency, quality of life measures, and side effects. MRI data will be analysed as secondary outcomes. MEDLINE, EMBASE, CINAHL, LILACS, CENTRAL and major trial registers will be searched for suitable studies. Titles and abstracts and full texts will be screened by two persons independently using Covidence. The risk of bias will be analysed based on the Cochrane “Risk of Bias 2” tool, and the certainty of evidence will be assessed using GRADE. Treatment effects will be reported as rate ratio or odds ratio. Primary analyses will follow the intention-to-treat principle. Meta-analyses will be carried out using random-effects models. Discussion: Given that individual patient data from clinical studies are often not available, the review will allow to analyse the evidence on TEM in MS immunotherapy and thus support clinical decision making in individual cases. Systematic review registration: PROSPERO CRD42021279665.


  • Challenges and Opportunities in Stroke Nursing Research: Global Views From a Panel of Nurse Researchers

    by Sheena Ramazanu, Cynthia Bautista, Theresa Green, Lori M. Rhudy, Maria Isabelita C. Rogado, Priya Baby, Caroline Woon, Rudolf Cymorr Kirby Palogan Martinez, Jane R. von Gaudecker, Peter Nydahl, et al.

    INTRODUCTION: A diverse group of neuroscience nurse experts discussed stroke nursing research at the 5th International Neuroscience Nursing Research Symposium. Panel experts from Singapore, India, Australia, New Zealand, the Philippines, Malawi, Germany, Palestine, Kenya, Japan, and the United States collaborated to examine similarities and differences in nurse-led stroke research conducted in their home countries. This article reflects panel insights on challenges and opportunities for nurse-led stroke research. DISCUSSION: The research challenges discussed include nursing independence, the processes of informed consent and randomization process, obtaining adequate independent funding, recruiting research subjects, and working with vulnerable groups. The major opportunities to leverage and improve stroke nursing research include facilitating the nurse investigator role, information digitalization, improving health literacy, and collaboration between nurse researchers. SUMMARY: We are living in a volatile, uncertain, complex, and ambiguous world, and the COVID-19 pandemic has accentuated many challenges. There is a need to allow for creativity around recruitment and conducting stroke research. The use of technology reduces travel needs and mitigates many safety, financial, and transportation-related problems. Although the pandemic has highlighted the challenges faced when conducting stroke-related research, there are remarkable similarities in opportunities to improve outcomes.